Majowicz, Anna
Spark Therapeutics (United States)
4 papers on CoChat
Most cited papers
- Verified
Therapeutic hFIX activity achieved after single AAV5-hFIX treatment in hemophilia b patients and NHPs with pre-existing anti-AAV5 NABs
Majowicz, A., Nijmeijer, B., Lampen, M. H., Spronck, L., de Haan, M., Petry, H., van Deventer, S. J., Meyer, C., Tangelder, M., & Ferreira, V. (2019) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 126
- Verified
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
Smith, C. J., Ross, N., Kamal, A., Kim, K. Y., Kropf, E., Deschatelets, P., Francois, C., Quinn, W. J., Singh, I., Majowicz, A., et al. (2022) · Frontiers in Immunology
Virus-based gene therapy researchImmunotherapy and Immune Responses
Cited by 86
- Verified · note
Complement System Response to Adeno-Associated Virus Vector Gene Therapy
Kropf, E., Markusic, D. M., Majowicz, A., Mingozzi, F., & Kuranda, K. (2024) · Human Gene Therapy
Virus-based gene therapy researchComplement system in diseases
Cited by 39
- Verified
Intravitreal AAV vector delivery induces integrin-dependent ocular inflammation, complement activation, and antiviral and DNA damage responses
Costa-Verdera, H., Jamwal, D., Fabyanic, E., Hippen, A., Salvatore, M., Du, A., Majowicz, A., Markusic, D., Chatterton, J. E., Haurigot, V., et al. (2026) · Frontiers in Immunology
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free